RNA interference targeting raptor inhibits proliferation of gastric cancer cells

Experimental Cell Research

Volumn 317, Issue 10, 2011, Pages 1353-1358

  Wu, William Ka Kei ^a   Lee, Chung Wa ^a   Cho, Chi Hin ^a   Chan, Francis Ka Leung ^a   Yu, Jun ^a   Sung, Joseph Jao Yiu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AP 1; Cell cycle; Gastric cancer; MTOR; Proliferation; Smad

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; STOMACH CANCER; UPREGULATION;

MAMMALIA; RAPTORES;

EID: 79955977489     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.03.005     Document Type: Article

References (28)

1. Menon S., Manning B.D. Common corruption of the mTOR signaling network in human tumors. Oncogene 2008, 27(Suppl 2):S43-S51.
2. Vander Haar E., Lee S.I., Bandhakavi S., Griffin T.J., Kim D.H. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007, 9:316-323.
3. Peterson T.R., Laplante M., Thoreen C.C., Sancak Y., Kang S.A., Kuehl W.M., Gray N.S., Sabatini D.M. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009, 137:873-886.
4. Mamane Y., Petroulakis E., LeBacquer O., Sonenberg N. mTOR, translation initiation and cancer. Oncogene 2006, 25:6416-6422.
5. Easton J.B., Houghton P.J. mTOR and cancer therapy. Oncogene 2006, 25:6436-6446.
6. Murayama T., Inokuchi M., Takagi Y., Yamada H., Kojima K., Kumagai J., Kawano T., Sugihara K. Relation between outcomes and localisation of p-mTOR expression in gastric cancer. Br J Cancer 2009, 100:782-788.
7. Kamata S., Kishimoto T., Kobayashi S., Miyazaki M., Ishikura H. Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells. Cancer Biol Ther 2007, 6:1036-1043.
8. Lang S.A., Hackl C., Moser C., Fichtner-Feigl S., Koehl G.E., Schlitt H.J., Geissler E.K., Stoeltzing O. Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochim Biophys Acta 2010, 1803:435-442.
9. Wu W.K., Wu Y.C., Yu L., Li Z.J., Sung J.J., Cho C.H. Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cells. Biochem Biophys Res Commun 2008, 374:258-263.
10. Shaulian E., Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400.
11. Wong B.C., Jiang X.H., Lin M.C., Tu S.P., Cui J.T., Jiang S.H., Wong W.M., Yuen M.F., Lam S.K., Kung H.F. Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase. Gastroenterology 2004, 126:136-147.
12. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002, 110:163-175.
13. Shigematsu H., Yoshida K., Sanada Y., Osada S., Takahashi T., Wada Y., Konishi K., Okada M., Fukushima M. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells. Int J Cancer 2010, 126:2716-2725.
14. Gandin V., Miluzio A., Barbieri A.M., Beugnet A., Kiyokawa H., Marchisio P.C., Biffo S. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008, 455:684-688.
15. Eferl R., Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003, 3:859-868.
16. Cho S.O., Lim J.W., Kim K.H., Kim H. Involvement of Ras and AP-1 in Helicobacter pylori-induced expression of COX-2 and iNOS in gastric epithelial AGS cells. Dig Dis Sci 2010, 55:988-996.
17. Ashktorab H., Daremipouran M., Wilson M., Siddiqi S., Lee E.L., Rakhshani N., Malekzadeh R., Johnson A.C., Hewitt S.M., Smoot D.T. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. Am J Gastroenterol 2007, 102:2135-2146.
18. Gao A., Liu B., Shi X., Jia X., Ye M., Jiao S., You B., Huang C. Phosphatidylinositol-3 kinase/Akt/p70S6K/AP-1 signaling pathway mediated benzo(a)pyrene-induced cell cycle alternation via cell cycle regulatory proteins in human embryo lung fibroblasts. Toxicol Lett 2007, 170:30-41.
19. Wang L.H., Kim S.H., Lee J.H., Choi Y.L., Kim Y.C., Park T.S., Hong Y.C., Wu C.F., Shin Y.K. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression. Clin Cancer Res 2007, 13:102-110.
20. Deng Z.H., Wen J.F., Li J.H., Xiao D.S., Zhou J.H. Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. World J Gastroenterol 2008, 14:1437-1443.
21. Yoo Y.D., Choi J.Y., Lee S.J., Kim J.S., Min B.R., Lee Y.I., Kang Y.K. TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells. Int J Cancer 1999, 83:512-517.
22. Vesely P.W., Staber P.B., Hoefler G., Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res 2009, 682:7-12.
23. Song K., Wang H., Krebs T.L., Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 2006, 25:58-69.
24. Abbas T., Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009, 9:400-414.
25. Miehlke S., Yu J., Ebert M., Szokodi D., Vieth M., Kuhlisch E., Buchcik R., Schimmin W., Wehrmann U., Malfertheiner P., Ehninger G., Bayerdörffer E., Stolte M. Expression of G1 phase cyclins in human gastric cancer and gastric mucosa of first-degree relatives. Dig Dis Sci 2002, 47:1248-1256.
26. Sheng G., Bernabe K.Q., Guo J., Warner B.W. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression. Gastroenterology 2006, 131:153-164.
27. Gorshtein A., Rubinfeld H., Kendler E., Theodoropoulou M., Cerovac V., Stalla G.K., Cohen Z.R., Hadani M., Shimon I. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocr Relat Cancer 2009, 16:1017-1027.
28. Schreiber M., Kolbus A., Piu F., Szabowski A., Möhle-Steinlein U., Tian J., Karin M., Angel P., Wagner E.F. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999, 13:607-619.